BB
Berkshire Bank’s Idexx Laboratories IDXX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $839K | Buy |
1,564
+7
| +0.4% | +$3.75K | 0.19% | 75 |
|
2025
Q1 | $654K | Buy |
1,557
+4
| +0.3% | +$1.68K | 0.16% | 86 |
|
2024
Q4 | $642K | Buy |
1,553
+80
| +5% | +$33.1K | 0.15% | 87 |
|
2024
Q3 | $744K | Buy |
1,473
+115
| +8% | +$58.1K | 0.17% | 82 |
|
2024
Q2 | $662K | Sell |
1,358
-22
| -2% | -$10.7K | 0.17% | 81 |
|
2024
Q1 | $745K | Buy |
1,380
+20
| +1% | +$10.8K | 0.19% | 84 |
|
2023
Q4 | $755K | Buy |
1,360
+2
| +0.1% | +$1.11K | 0.2% | 81 |
|
2023
Q3 | $594K | Sell |
1,358
-21
| -2% | -$9.18K | 0.17% | 84 |
|
2023
Q2 | $693K | Sell |
1,379
-5
| -0.4% | -$2.51K | 0.19% | 80 |
|
2023
Q1 | $692K | Sell |
1,384
-30
| -2% | -$15K | 0.21% | 79 |
|
2022
Q4 | $577K | Sell |
1,414
-195
| -12% | -$79.6K | 0.18% | 86 |
|
2022
Q3 | $524K | Buy |
1,609
+31
| +2% | +$10.1K | 0.16% | 86 |
|
2022
Q2 | $553K | Buy |
1,578
+18
| +1% | +$6.31K | 0.16% | 84 |
|
2022
Q1 | $854K | Buy |
1,560
+79
| +5% | +$43.2K | 0.2% | 76 |
|
2021
Q4 | $975K | Buy |
1,481
+34
| +2% | +$22.4K | 0.22% | 75 |
|
2021
Q3 | $900K | Sell |
1,447
-25
| -2% | -$15.5K | 0.22% | 79 |
|
2021
Q2 | $930K | Buy |
1,472
+36
| +3% | +$22.7K | 0.22% | 78 |
|
2021
Q1 | $702K | Buy |
1,436
+1
| +0.1% | +$489 | 0.18% | 82 |
|
2020
Q4 | $717K | Buy |
1,435
+317
| +28% | +$158K | 0.18% | 78 |
|
2020
Q3 | $440K | Buy |
+1,118
| New | +$440K | 0.12% | 97 |
|